Literature DB >> 15249138

Inhibitors of protein phosphatase-2A: topography and subcellular localization.

Hitoshi Tanimukai1, Inge Grundke-Iqbal, Khalid Iqbal.   

Abstract

The mRNA and protein expressions of I1(PP2A) and I2(PP2A), the two inhibitors of protein phosphatase 2A (PP2A) were investigated in adult rat brain. The rat brain and human brain inhibitors showed similar molecular weights by Western blots. The cDNA probes for human brain I1(PP2A) and I2(PP2A) readily hybridized with the corresponding mRNAs of rat brain inhibitors in Northern blots. We detected 3.7 and 2.1 kb transcripts of I1(PP2A) and 2.9 and 2.0 kb transcripts of I2(PP2A) in rat brain. In situ hybridization revealed that the mRNAs of the two inhibitors were mainly localized in neurons. Strong expression of both I1(PP2A) and I2(PP2A) mRNAs were observed in the olfactory bulb, hippocampal pyramidal and dentate granule cell layers, and cerebellar Purkinje cell, granular and molecular layers. Moderate expression of I1(PP2A) and I2(PP2A) mRNAs were observed in the cerebral cortex, caudate putamen, thalamus, hypothalamus, amygdala and pontine nucleus. The expression of I1(PP2A) and I2(PP2A) and as well as of PP-2A was also investigated by immunohistochemistry using antibodies to each protein. The distribution patterns of the two inhibitor proteins were similar to those of their corresponding mRNAs and to the expression of PP-2A. While PP-2A was localized to neuronal perikarya, I1(PP2A) was observed both in the neuronal cytoplasm and the nucleus. I2(PP2A) had mainly nuclear localization but it could also be seen in the neuronal cytoplasm. All three proteins were also expressed in the neuropil. These studies suggest that PP-2A activity is probably regulated by I1(PP2A) and I2(PP2A) in the adult mammalian central nervous system, and that these inhibitors are conserved between rat and human brains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249138     DOI: 10.1016/j.molbrainres.2004.04.003

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

1.  Regulation of protein phosphatase 1I by Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE protein kinase.

Authors:  Jimcy Platholi; Anna Federman; Julia A Detert; Paul Heerdt; Hugh C Hemmings
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

2.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.

Authors:  Hitoshi Tanimukai; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 3.  Novel therapeutic strategies for neurodegenerative disease.

Authors:  Hitoshi Tanimukai; Takashi Kudo; Toshihisa Tanaka; Inge Grundke-Iqbal; Khalid Iqbal; Masatoshi Takeda
Journal:  Psychogeriatrics       Date:  2009-06       Impact factor: 2.440

4.  Failure of neuronal maturation in Alzheimer disease dentate gyrus.

Authors:  Bin Li; Hidenaga Yamamori; Yoshitaka Tatebayashi; Bridget Shafit-Zagardo; Hitoshi Tanimukai; She Chen; Khalid Iqbal; Inge Grundke-Iqbal
Journal:  J Neuropathol Exp Neurol       Date:  2008-01       Impact factor: 3.685

5.  I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A.

Authors:  She Chen; Bin Li; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

6.  Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.

Authors:  Xiaochuan Wang; Julie Blanchard; Inge Grundke-Iqbal; Jerzy Wegiel; Han-Xiang Deng; Teepu Siddique; Khalid Iqbal
Journal:  Acta Neuropathol       Date:  2013-10-18       Impact factor: 17.088

7.  14-3-3 Binding to ataxin-1(ATXN1) regulates its dephosphorylation at Ser-776 and transport to the nucleus.

Authors:  Shaojuan Lai; Brennon O'Callaghan; Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

8.  Genome-wide copy-number variation study of psychosis in Alzheimer's disease.

Authors:  X Zheng; F Y Demirci; M M Barmada; G A Richardson; O L Lopez; R A Sweet; M I Kamboh; E Feingold
Journal:  Transl Psychiatry       Date:  2015-06-02       Impact factor: 6.222

9.  Hyperphosphorylation-induced tau oligomers.

Authors:  Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Front Neurol       Date:  2013-08-15       Impact factor: 4.003

10.  CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment.

Authors:  Qing Zhang; Yiyuan Xia; Yongjun Wang; Yangping Shentu; Kuan Zeng; Yacoubou A R Mahaman; Fang Huang; Mengjuan Wu; Dan Ke; Qun Wang; Bin Zhang; Rong Liu; Jian-Zhi Wang; Keqiang Ye; Xiaochuan Wang
Journal:  Front Mol Neurosci       Date:  2018-04-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.